Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13951 - 13975 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:0050589 inflammatory bowel disease HGNC:914 Homo sapiens (human) 567 B2M mutant phenotype evidence used in manual assertion
  • PMID:20015205
DOID:162 cancer WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 mutant phenotype evidence used in manual assertion
  • PMID:21572423
DOID:0111442 optic atrophy 9 SGD:S000004295 Saccharomyces cerevisiae S288C 851013 ACO1 mutant phenotype evidence used in manual assertion
  • PMID:33028849
DOID:14330 Parkinson's disease SGD:S000003394 Saccharomyces cerevisiae S288C 853071 TIF4631 mutant phenotype evidence used in manual assertion
  • PMID:25533483
DOID:0060001 withdrawal disorder RGD:3435 Rattus norvegicus (Norway rat) 24929 Ptger3 mutant phenotype evidence used in manual assertion
  • PMID:10708732
DOID:3717 gastric adenocarcinoma HGNC:18505 Homo sapiens (human) 54894 RNF43 mutant phenotype evidence used in manual assertion
  • PMID:30380024
DOID:3748 esophagus squamous cell carcinoma HGNC:3227 Homo sapiens (human) 1948 EFNB2 mutant phenotype evidence used in manual assertion
  • PMID:29190834
DOID:707 B-cell lymphoma HGNC:11919 Homo sapiens (human) 958 CD40 mutant phenotype evidence used in manual assertion
  • PMID:20616215
DOID:10652 Alzheimer's disease HGNC:600 Homo sapiens (human) 335 APOA1 mutant phenotype evidence used in manual assertion
  • PMID:20847045
DOID:9975 cocaine dependence RGD:61862 Rattus norvegicus (Norway rat) 29627 Gria2 mutant phenotype evidence used in manual assertion
  • PMID:20555310
DOID:1070 primary open angle glaucoma HGNC:7610 Homo sapiens (human) 4653 MYOC mutant phenotype evidence used in manual assertion
  • PMID:23876925
DOID:614 lymphopenia RGD:2299 Rattus norvegicus (Norway rat) 25660 Cd28 mutant phenotype evidence used in manual assertion
  • PMID:12750179
DOID:4780 anti-basement membrane glomerulonephritis RGD:708418 Rattus norvegicus (Norway rat) 84349 Cd40lg mutant phenotype evidence used in manual assertion
  • PMID:15458437
DOID:9351 diabetes mellitus WB:WBGene00003858 Caenorhabditis elegans 176000 ogt-1 mutant phenotype evidence used in manual assertion
  • PMID:31576392
DOID:7148 rheumatoid arthritis HGNC:9605 Homo sapiens (human) 5743 PTGS2 mutant phenotype evidence used in manual assertion
  • PMID:21905970
DOID:0050879 fragile X-associated tremor/ataxia syndrome HGNC:3775 Homo sapiens (human) 2332 FMR1 mutant phenotype evidence used in manual assertion
  • PMID:15876460
DOID:3525 middle cerebral artery infarction RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:24471927
DOID:1588 thrombocytopenia HGNC:7217 Homo sapiens (human) 4352 MPL mutant phenotype evidence used in manual assertion
  • PMID:32841939
DOID:2526 prostate adenocarcinoma HGNC:7553 Homo sapiens (human) 4609 MYC mutant phenotype evidence used in manual assertion
  • PMID:14522256
  • PMID:20195545
DOID:11132 prostatic hypertrophy HGNC:30620 Homo sapiens (human) 80310 PDGFD mutant phenotype evidence used in manual assertion
  • PMID:22689130
DOID:916 liver benign neoplasm HGNC:28981 Homo sapiens (human) 23318 TUT4 mutant phenotype evidence used in manual assertion
  • PMID:24056962
DOID:3748 esophagus squamous cell carcinoma HGNC:3595 Homo sapiens (human) 2195 FAT1 mutant phenotype evidence used in manual assertion
  • PMID:24590895
DOID:5176 renal Wilms' tumor HGNC:3527 Homo sapiens (human) 2146 EZH2 mutant phenotype evidence used in manual assertion
  • PMID:18467665
DOID:6432 pulmonary hypertension HGNC:7176 Homo sapiens (human) 4318 MMP9 mutant phenotype evidence used in manual assertion
  • PMID:21063214
DOID:5844 myocardial infarction RGD:70982 Rattus norvegicus (Norway rat) 84027 Gsk3b mutant phenotype evidence used in manual assertion
  • PMID:16565311
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025